Home
Freenome

Freenome Market Share Analysis for June 2026

Freenome is led by an experienced management team and backed by exemplary institutional and strategic investors with substantial oncology, diagnostics, and operational expertise.

Computers Electronics and Technology > Web Hosting and Domain Names

Domainfreenome.com

Year Founded2014

Employees201 - 500

Annual Revenue$500M - $1B

Freenome

Freenome (including company regionals)

freenome.com

See more website traffic and engagement information

Freenome Revenue up to June 2026 is 500M - 1B

revenue generated by Freenome top domains

Freenome top domains revenue over 3 years

Revenue for Freenome top domains

freenome.com500M - 1B

See more with Sales Intelligence

Total visits to Freenome's top domains

Understand Freenome market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

freenome.com19.9K

See more with Sales Intelligence

Avg. visit duration in Freenome's top domains

Analyze Freenome engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

freenome.com00:01:01

See more with Sales Intelligence

Avg. pageviews on Freenome's top domains

See how Freenome keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

freenome.com3.31

See more with Sales Intelligence

Freenome top competitors by domain

Top similar sites in June 2026, ranked by their affinity

kariusdx.comCompany NameKariusEmployees51 - 200HQUnited States, California, Redwood CityAnnual revenue$15M - $25MTotal visits7.7KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Freenome

These are the website technologies, by industry, used by Freenome top domains

Advertising (7)

DoubleClick

Content Management System (6)

WordPress

Email Services (5)

G Suite

Widget (5)

Twemoji

More Technologies

14

See all

News & Signals from Freenome

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsFreenome Holdings, Inc is developing blood-based tests for early cancer detection.Freenome is developing blood-based tests for early cancer detection using a multiomics platform combined with artificial intelligence and machine learning.

NewsFreenome Holdings, Inc identified as competitor of Guardant Health.Freenome's main competitor in colorectal cancer detection will be Guardant Health, whose Shield test was the first FDA-approved liquid biopsy for this type of cancer.

NewsFreenome Holdings, Inc is planning to receive financing of $75M in investment.* Freenome will receive a $75 million investment from Roche as part of a deal that could be worth more than $200 million.